ライフサイエンスコーパス: critically ill

1 undergoing cardiac surgery, and 692 who were critically ill.

2 might be associated with poor outcome in the critically ill.

3 ions of emergency department boarding of the critically ill.

4 tcome set to inform delirium research in the critically ill.

5 s adversely associated with prognosis in the critically ill.

6 ophysiology of AKI in other patients who are critically ill.

7 nity to follow the molecular response in the critically ill.

8 risk factors for diagnostic errors among the critically ill.

9 -confirmed COVID-19, of which 257 (22%) were critically ill.

10 nly in a fraction of patients as they became critically ill.

11 69.6% were kidney recipients, and 25.0% were critically ill.

12 y of emergency department boarding among the critically ill, (2) the outcomes associated with critica

13 rious treatment modalities, and mortality in critically ill adult hemophagocytic lymphohistiocytosis

14 Critically ill adult mechanically ventilated coronavirus

15 April 2013 through April 2014, we recruited critically ill adult patients (>=18 years) with severe A

16 my is a very common clinical intervention in critically ill adult patients.

17 Critically ill adults (>=18 years) undergoing tracheal i

18 d with a reduction in acute kidney injury in critically ill adults (odds ratio, 0.47; 95% CI, 0.34-0.

19 al trial, with 3,957 mechanically ventilated critically ill adults allocated to energy-dense (1.5 kca

20 n complication during tracheal intubation of critically ill adults and may increase the risk of cardi

21 Observational studies among critically ill adults have associated receipt of balance

22 umerous risk factors for sleep disruption in critically ill adults have been described.

23 analysis of multicenter randomized trials of critically ill adults in which mortality was the main en

24 k ventilation) during tracheal intubation of critically ill adults prevents hypoxemia without increas

25 Among critically ill adults undergoing tracheal intubation, pa

26 ve care units (ICUs), we enrolled conscious, critically ill adults who had a tracheostomy tube; patie

27 Four critically ill adults with coronavirus disease 19 pneumo

28 is campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COV

29 ports of mortality rates exceeding 50% among critically ill adults with coronavirus disease 2019, par

30 pace to accommodate the increasing number of critically ill adults with coronavirus disease 2019.

31 conducted a multicenter cohort study of 3099 critically ill adults with COVID-19 admitted to intensiv

32 ds: Two prospective UK studies recruited 360 critically ill adults with new or worsening alveolar sha

33 Critically ill adults with unplanned admission to the me

34 PICU physician colleagues to care for these critically ill adults.

35 infusion strategy on acute kidney injury in critically ill adults.

36 cardiovascular collapse during intubation of critically ill adults.

37 high-flow nasal cannula after extubation in critically ill adults.

38 s in minority-serving hospitals.Conclusions: Critically ill African American individuals are dispropo

39 ant ethical considerations in caring for the critically ill and facilitates patient-centered, evidenc

40 sess gut-associated microbial communities in critically ill and healthy infants, facilitated by NanoO

41 tal stays for medical patients (patients not critically ill and not undergoing surgical procedures) a

42 Most patients (74%; 37/50) were critically ill and treated on intensive care unit.

43 y was eligible if studies were done in adult critically ill, applied any type of electroencephalograp

44 We suggest that these patients may become critically ill because of monogenic inborn errors that d

45 valuate the prevalence of rehabilitation for critically ill children and associated barriers.

46 Critically ill children are frequently exposed to noninv

47 ions of difficult bag-mask ventilation among critically ill children are not well studied.

48 sign of rehabilitation interventions for all critically ill children at risk of functional impairment

49 The Bleeding Assessment Scale in Critically Ill Children definition of clinically relevan

50 driven definition applicable for bleeding in critically ill children derived via international expert

51 t the greatest clinical risk and to identify critically ill children in whom malaria is not the prima

52 y treatments, and predictors of mortality in critically ill children with ADHF.

53 This study challenges the notion that critically ill children with asymptomatic CVC-related th

54 In critically ill children, NMR metabolomics differentiates

55 ypothesized that in a heterogeneous group of critically ill children, there would be different metabo

56 Delirium occurs frequently in critically ill children, with highest rates reported in

57 e as a monitoring device for hemodynamics in critically ill children.

58 widely used to avoid tracheal intubation in critically ill children.

59 method of monitoring intestinal dysbiosis in critically ill children.

60 is essential for appropriate drug dosing in critically ill children.

61 spectra were acquired in plasma samples from critically ill children.

62 sely associated with short-term mortality in critically ill cirrhotic patients.

63 Overall mortality to date in this critically ill cohort is 30.9% (67/217) and 60.4% (131/2

64 Findings were similar in the surgical and critically ill cohorts.

65 obal urinary and fecal metabolic profiles in critically ill compared with healthy children.

66 characteristics, treatment, and outcomes of critically ill coronavirus disease 2019 (COVID-19) solid

67 One-hundred nine critically ill coronavirus disease 2019 patients admitte

68 e the frequency of venous thromboembolism in critically ill coronavirus disease 2019 patients and ass

69 nt of meeting current and projected needs of critically ill coronavirus disease 2019 patients.

70 We found a high incidence of CAPA among critically ill COVID-19 patients and that its occurrence

71 Critically ill COVID-19 patients, but not those with mil

72 To overcome the surge of critically ill COVID-19 patients, reallocating health ca

73 surgeons decide among management options for critically-ill EGS patients.

74 Boarding of the critically ill has achieved specific attention because o

75 Only 1 mortality (4.8%) to date, in a critically ill heart/kidney patient who had been in the

76 post hoc analysis of a prospective cohort of critically ill hematology patients admitted to 17 ICUs.

77 r airway by multiplex PCR assay is common in critically ill hematology patients.

78 ectively investigating treatment tailored to critically ill hemophagocytic lymphohistiocytosis patien

79 on for gram-negative HABP/VABP, including in critically ill, high-risk patients.

80 iation of mortality with elevated KSHV-VL in critically ill HIV-infected patients with suspected but

81 tice of using thromboembolic prophylaxis for critically ill hospitalized patients, and standard suppo

82 In March 2020, we treated a cohort of 26 critically ill hospitalized SARS-CoV-2-infected patients

83 ICU and comparison to the mortality of other critically ill ICU patients classified into six other di

84 set atrial fibrillation in a large cohort of critically ill ICU patients, suggesting there is genetic

85 models in a novel population of largely non-critically ill immunocompromised pediatric patients, and

86 lf-isolation, when R (0) = 2.5, treatment of critically ill individuals at the outbreak peak would re

87 ve bacterial pathogen that primarily infects critically ill individuals.

88 ribe qualitative and quantitative CC size in critically ill infants following surgical and critical c

89 Fungal disease occurs frequently in critically ill, mechanically ventilated COVID-19 patient

90 In critically ill, mechanically ventilated patients, daily

91 tionally recommends chemoprophylaxis for non-critically ill medical inpatients, leaving much to the d

92 or rIFN-beta1a) therapy was commonly used in critically ill MERS patients but was not associated with

93 blood and PBMCs were undertaken in control, critically ill nonseptic, and septic patients.

94 Across 11 studies, compared with critically ill nonseptic, septic patients had significan

95 Survival in critically ill oncology and hematology patients with sep

96 n-pharmacological techniques if infants were critically ill or a structural magnetic resonance imagin

97 We considered any outcome related to the critically ill patient and/or their family member, outco

98 Emergency department-based boarding of the critically ill patient is common, but no nationally repr

99 thy should be managed as it would be for any critically ill patient, following the established practi

100 chnical airway skills involved in managing a critically ill patient.

101 gs attention to the respiratory drive of the critically ill patient.

102 Very few articles pertained to transport of critically ill patients (4%).

103 m 53% in mild-to-moderate patients to 88% in critically ill patients (p=0.036).

104 phalopathy severity by Glasgow Coma Scale in critically ill patients (rho, -0.54; p = 0.036).

105 ependently predicts in-hospital mortality in critically ill patients across the glycemic spectrum.

106 nd platelet activation in critically and non-critically ill patients admitted to the hospital with CO

107 ied in serum from 321 prospectively enrolled critically ill patients and compared with clinical outco

108 ghlighted other important considerations for critically ill patients and evaluated interventions to r

109 evidence on fluid overload and mortality in critically ill patients and have performed a meta-analys

110 lternative complement pathway in a series of critically ill patients and in a mouse pneumonia model.M

111 is a common cause of respiratory failure in critically ill patients and is defined by the acute onse

112 ze acute alterations of circadian rhythms in critically ill patients and to evaluate associations bet

113 e multicentral database of perioperative and critically ill patients and to use this automatic algori

114 ctives: To determine if clinical outcomes of critically ill patients are predicted by features of the

115 equations against indirect calorimetry among critically ill patients at different phases of critical

116 strategies that improve clinical outcomes of critically ill patients boarded in the emergency departm

117 due to sepsis remains a persistent threat to critically ill patients confined to the intensive care u

118 More notably, critically ill patients displayed hallmarks of extrafoll

119 Rehabilitation interventions in critically ill patients do not influence mortality and a

120 Critically ill patients for whom the physician decided t

121 Recent research in critically ill patients has highlighted other important

122 powerful diagnostic and prognostic marker in critically ill patients has recently accumulated.

123 oninferiority trial designs and exclusion of critically ill patients in many trials.

124 pportunistic pathogen that primarily infects critically ill patients in nosocomial settings.

125 sts its possible role in the routine care of critically ill patients in the future.

126 P tool may be used in the future to stratify critically ill patients in the ICU according to their im

127 Uses of ketamine discussed focused on critically ill patients in the ICU and emergency departm

128 remains in identifying the immune profile of critically ill patients in the intensive care unit (ICU)

129 Although one third or more of critically ill patients in the United States are obese,

130 ture of COVID-19 and the large population of critically ill patients included in these analyses, the

131 benefit in several disease states impacting critically ill patients including pain, alcohol withdraw

132 t that chronic and current alcohol misuse in critically ill patients is associated with kidney dysfun

133 aims at showing that anxiety at admission in critically ill patients is associated with new organ fai

134 Critically ill patients rapidly enter a state of behavio

135 the prevalence of venous thromboembolism in critically ill patients receiving different regimens of

136 nctive intermittent pneumatic compression in critically ill patients receiving pharmacologic thrombop

137 Its incidence and outcome in critically ill patients remain, however, largely unknown

138 sed as an inotropic and vasopressor agent in critically ill patients requiring hemodynamic support.

139 Critically ill patients routinely receive vancomycin as

140 Almost 10% of these critically ill patients subsequently die.

141 specially compared with other populations of critically ill patients such as sepsis or severe communi

142 100% occurrence of venous thromboembolism in critically ill patients supported by venovenous extracor

143 or of TimeSignature was higher in individual critically ill patients than healthy patients (4.90 vs 1

144 pecific clinical characteristics of infected critically ill patients that mediate the associated path

145 ranging from the morbidity and mortality of critically ill patients to the diagnosis and prognosis o

146 egy on organ injury are less well studied in critically ill patients treated with continuous kidney r

147 e analysis of circulating cytokine levels in critically ill patients treated with mesenchymal stem/st

148 atient-ventilator asynchrony is common among critically ill patients undergoing mechanical ventilatio

149 Engaging and empowering families of critically ill patients warrant further study.

150 Emergency department boarding of critically ill patients was common and was associated wi

151 Mortality among these critically ill patients was high.

152 t least 24 hours and conventional therapy in critically ill patients were included.

153 n.Measurements and Main Results: Lungs of 91 critically ill patients were sampled using miniature BAL

154 n prominent IFN signatures were only seen in critically ill patients who also exhibited augmented inf

155 Participants were critically ill patients who regained mental capacity fol

156 Among critically ill patients with acute kidney injury receivi

157 t practices in renal replacement therapy for critically ill patients with acute kidney injury.

158 a potential infective complication affecting critically ill patients with acute respiratory distress

159 Participants included critically ill patients with AKI requiring RRT who were

160 h independently associated with mortality in critically ill patients with AKI requiring RRT.

161 r a high CO2 gap predicts mortality in adult critically ill patients with circulatory shock.

162 Ogilvie syndrome, mesenteric ischemia) among critically ill patients with coronavirus disease 2019 (C

163 mor necrosis factor alpha, IL-6, and IL-8 in critically ill patients with coronavirus disease 2019 (C

164 A large proportion of critically ill patients with coronavirus disease 2019 ha

165 organ failure, and could improve survival in critically ill patients with coronavirus disease 2019 in

166 We reviewed thromboelastography studies in critically ill patients with coronavirus disease 2019 to

167 In this cohort of critically ill patients with coronavirus disease 2019, n

168 Deep venous thrombosis is very common in critically ill patients with coronavirus disease 2019.

169 rohemorrhages were brain imaging features in critically ill patients with coronavirus disease 2019.

170 he cytokine milieu in the lungs and blood of critically ill patients with COVID-19 acute respiratory

171 In this study of critically ill patients with COVID-19 and acute respirat

172 AKI-RRT is common among critically ill patients with COVID-19 and is associated

173 Care) genome-wide association study in 2,244 critically ill patients with COVID-19 from 208 UK intens

174 idemiology, clinical course, and outcomes of critically ill patients with COVID-19 in this setting ar

175 nsive care unit (ICU) stay suggest that many critically ill patients with COVID-19 will face long-las

176 authors report brain imaging features in 11 critically ill patients with COVID-19 with persistently

177 irement were similar between SOT and non-SOT critically ill patients with COVID-19.

178 nthetic glucocorticoid, enhanced survival of critically ill patients with COVID-19.

179 arries a high risk of complications; half of critically ill patients with difficult airways experienc

180 atients with diseases of other major organs, critically ill patients with ESKD were not more likely t

181 retrospective, observational study included critically ill patients with influenza associated with p

182 In this case series of critically ill patients with laboratory-confirmed COVID-

183 This is a retrospective cohort study of critically ill patients with laboratory-confirmed MERS f

184 ntly associated with short-term mortality in critically ill patients with liver cirrhosis.

185 rferon (RBV/rIFN) therapy on the outcomes of critically ill patients with Middle East respiratory syn

186 to confirm merits of nebulized amikacin for critically ill patients with nosocomial pneumonia.

187 the most challenging problems in the care of critically ill patients with oliguric acute kidney injur

188 Critically ill patients with requirement of continuous r

189 Critically ill patients with sepsis or septic shock are

190 sal and potentially biomarker information in critically ill patients with sepsis.

191 o bring precision medicine to the bedside of critically ill patients with sepsis.

192 m the Adjunctive Corticosteroid Treatment in Critically Ill Patients with Septic Shock and Activated

193 m the Adjunctive Corticosteroid Treatment in Critically Ill Patients with Septic Shock and Activated

194 d for Adjunctive Corticosteroid Treatment in Critically Ill Patients with Septic Shock and hydrocorti

195 ,658 (Adjunctive Corticosteroid Treatment in Critically Ill Patients with Septic Shock) and $30,911 (

196 Per Adjunctive Corticosteroid Treatment in Critically Ill Patients with Septic Shock, adjunctive hy

197 The trial was terminated early after 596 critically ill patients with severe acute kidney injury

198 hypotension during vasopressor support among critically ill patients with shock and to determine whet

199 on and adverse kidney-related outcomes among critically ill patients with shock.Objectives: To invest

200 predictive value for bacterial pneumonia in critically ill patients with suspected infection.

201 wever, the evidence base guiding the care of critically ill patients with tuberculous meningitis is p

202 r positive end-expiratory pressure (PEEP) in critically ill patients without acute respiratory distre

203 Compared with critically ill patients without major organ disease, pat

204 Usual care (critically ill patients) and modified constant routine (

205 myocardial injury from the infection (22% of critically ill patients).

206 ean Outcome Registry in ICUs) enrolled 2,087 critically ill patients, and AdrenOSS-1 (Adrenomedullin

207 ll patients, very specific subpopulations of critically ill patients, and on early goal-directed ther

208 Cancer affects up to 20% of critically ill patients, and sepsis is one of the leadin

209 entral venous catheters, are often needed in critically ill patients, but also are associated with co

210 s are preparing for the anticipated surge in critically ill patients, but few are wholly equipped to

211 Frailty has prognostic importance among critically ill patients, but its impact on outcomes and

212 n was effective in enhancing the recovery of critically ill patients, but more large-scale, multicent

213 d a high diagnostic yield for these selected critically ill patients, even in the presence of multipl

214 ute lung injury (ALI), a common condition in critically ill patients, has limited treatments and high

215 We studied 15 critically ill patients, including 10 with sepsis and fi

216 We studied 112 critically ill patients, including 53 with sepsis and 59

217 We studied 112 critically ill patients, including 53 with sepsis and 59

218 to address emergency department boarding of critically ill patients, including emergency department-

219 among patients with ESKD compared with other critically ill patients, including those with diseases o

220 ith early occurrence of new organ failure in critically ill patients, independently of respiratory st

221 onale: Recent studies have revealed that, in critically ill patients, lung microbiota are altered and

222 Among 217 critically ill patients, mortality for those who require

223 In peripheral blood of critically ill patients, Orai1+ cells were significantly

224 ibe the determinants of respiratory drive in critically ill patients, review the tools available to a

225 Among critically ill patients, the benefits of nutrition suppo

226 for continuous kidney replacement therapy in critically ill patients, the evidence for this recommend

227 In critically ill patients, treatment dose or intensity is

228 In critically ill patients, we showed that mitophagy was in

229 with hypoxia and hemodynamic instability in critically ill patients.

230 med for prolonged endotracheal intubation in critically ill patients.

231 Hyperferritinemia is frequently seen in critically ill patients.

232 tensive care unit, with a proven benefit for critically ill patients.

233 the pathophysiology of respiratory drive in critically ill patients.

234 s, our institution prepared for an influx of critically ill patients.

235 ardiography as a predictor of outcomes among critically ill patients.

236 ility, organ injury and improved outcomes in critically ill patients.

237 organ support and of short-term mortality in critically ill patients.

238 e respiratory distress syndrome is common in critically ill patients.

239 ologic outcome compared with normothermia in critically ill patients.

240 oalveolar lavage and cerebrospinal fluids of critically ill patients.

241 ting reversibility of acute kidney injury in critically ill patients.

242 the reversibility of acute kidney injury in critically ill patients.

243 own about their impact on the outcome of non-critically ill patients.

244 nt is not associated with a worse outcome in critically ill patients.

245 was associated with increase risk of harm in critically ill patients.

246 ement of impaired intestinal transit even in critically ill patients.

247 rt toward improving the delivery of care for critically ill patients.

248 Tracheal intubation is commonly performed in critically ill patients.

249 general population and defined subgroups of critically ill patients.

250 nfluencing delivery of early mobilization to critically ill patients.

251 intensive care-applied therapies applied to critically ill patients.

252 clock genes in healthy controls, but none in critically ill patients.

253 Consecutive endotracheal intubations in critically ill patients.

254 gnized clinical problem, typically occurs in critically ill patients.

255 ionale: Acidemia is a severe condition among critically ill patients.

256 es of hyperferritinemia in a mixed cohort of critically ill patients.

257 help expand the donor pool in this subset of critically ill patients.

258 s with modern emergency airway management in critically ill patients.

259 aining who may be suddenly asked to care for critically ill patients.

260 ment of acquired liver injury and failure in critically ill patients.

261 amples from a cohort of septic and nonseptic critically ill patients.

262 nation method for endotracheal intubation in critically ill patients.

263 ill continue to enhance our ability to treat critically ill patients.

264 xamination findings with 90-day mortality in critically ill patients.

265 n MRI at the point of care, particularly for critically ill patients.

266 ctability in extubation failure detection in critically ill patients.

267 should be not used to track contractility in critically ill patients.

268 nary artery occlusion pressure in ventilated critically ill patients.

269 quently required for mechanically ventilated critically ill patients.

270 e of admission to the intensive care unit in critically ill patients.

271 and safe assessing thromboembolic disease in critically ill patients.

272 ten results in significant fluid overload in critically ill patients.

273 ate that is both common and consequential in critically ill patients.

274 e measure of the central circadian rhythm in critically ill patients.

275 N ratio correlated with improved outcome for critically ill patients.

276 gut-associated bacteria) predict outcomes in critically ill patients.

277 of epinephrine administration on outcome of critically ill patients.

278 lues, the features more commonly observed in critically ill patients.(C) RSNA, 2020.

279 rving hospitals using an inception cohort of critically ill patients.Measurements and Main Results: U

280 (CKRT) can be a lifesaving intervention for critically ill patients; however, mortality remains high

281 smission and subsequent ESBL-E infections in critically-ill patients.

282 RTICIPANTS: Descriptive feasibility study of critically ill pediatric patients with suspected monogen

283 easibility of ultra-rapid genomic testing in critically ill pediatric patients with suspected monogen

284 tracorporeal membrane oxygenation to support critically ill, poisoned patients in the United States i

285 with previous descriptions of endotypes in a critically ill population with acute respiratory distres

286 umatic stress disorder were similar to other critically ill populations and were related to physical

287 thods: We measured early plasma sRAGE in two critically ill populations with sepsis.

288 ve transfusion strategies in the majority of critically ill populations.

289 400 hospital-admitted COVID-19 patients (144 critically ill) primarily receiving standard-dose prophy

290 In the critically ill, radiographically confirmed VTE and major

291 with matched hospital controls, costs of the critically ill remained higher throughout the follow-up.

292 Critically ill septic and nonseptic patients.

293 Critically ill surgical patients may receive concomitant

294 Concomitant aspirin and anticoagulation in critically ill surgical patients was associated with an

295 Among critically ill surgical sepsis patients, persistent AKI

296 We report for the first time in the critically ill that specific videolaryngoscopy skill tra

297 1,267 serum and respiratory samples from 719 critically ill UK patients with COVID-19 and suspected p

298 ial of early vitamin D(3) supplementation in critically ill, vitamin D-deficient patients who were at

299 with laboratory-confirmed COVID-19 and were critically ill with acute hypoxaemic respiratory failure

300 involved in many levels of care for patients critically ill with COVID-19.